| 摘要 |
This invention relates to the use of a plant extract, derived from a Salvia spp, comprising one or more tanshinone compounds, or said one or more tanshinone compounds, in the treatment of wounds, particularly chronic wounds, or other conditions benefiting from inhibition of Cortisol production, particularly Cushing's syndrome. Preferred tanshinone compounds include, but are not limited to, dihydrotanshinone (particularly 15,16- dihydrotanshinone (CAS No. 87205-99-0) ) and Tanshinone I. |
